CLINICAL_TRIALS
trial_result
· 2016-02-15
Clinical Trial Update: Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer [Phase 2]
Summary
Phase 2 trial of pemetrexed with bevacizumab in head and neck cancer has completed enrollment, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pittsburgh | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-15